Statement of Principles concerning carotid arterial disease No. 9 of 2003
- F2005C00668
Superseded | View Series
9/2003 Determinations as amended, taking into account amendments up to Repatriation Medical Authority Instrument No. 29 of 2003
Administered by: Veterans' Affairs
Prepared 20 Oct 2005 by Agency
Prepared 20 Oct 2005
Registered 28 Oct 2005
Start Date 16 Jul 2003
Date of Ceasing: Ceased 02 May 2012 on the first moment of the day
Reason for Ceasing: Revoked by Statement of Principles concerning carotid arterial disease No. 37 of 2012
Skip Navigation Links.

 

Statement of Principles

concerning

CAROTID ARTERIAL DISEASE

Instrument No. 9 of 2003 as amended

made under section 196B(2) of the

This compilation was prepared on 20 October 2005
taking into account
Amendment of Statement of Principles concerning CAROTID ARTERIAL DISEASE (Instrument No. 29 of 2003)

Prepared by the Repatriation Medical Authority Secretariat, Brisbane


Revocation and Determination

of

Statement of Principles

concerning

 

CAROTID ARTERIAL DISEASE

 

 

Veterans’ Entitlements Act 1986

 

 

1.         The Repatriation Medical Authority under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the Act):

 

(a)       revokes Instrument No.346 of 1995; and

 

(b)       determines in its place the following Statement of Principles.

 

Kind of injury, disease or death

2.         (a)       This Statement of Principles is about carotid arterial disease and death from carotid arterial disease.

 

(b)  For the purposes of this Statement of Principles, “carotid arterial disease” means the

(i)                occlusion or stenosis of the common, internal or external carotid artery due to atherosclerosis, dissection or other pathological process involving that artery, or

(ii)             aneurysm of the common, internal or external carotid artery.

 

(c)  Carotid arterial disease attracts ICD-10-AM code I65.2 or I72.0.

 

(d)  In the application of this Statement of Principles, the definition of “carotid arterial disease” is that given at para 2(b) above.

 

Basis for determining the factors

3.         The Repatriation Medical Authority is of the view that there is sound medical-scientific evidence that indicates that carotid arterial disease and death from carotid arterial disease can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces.

 

Factors that must be related to service

4.         Subject to clause 6, at least one of the factors set out in clause 5 must be related to any relevant service rendered by the person.

 

Factors

5.         The factors that must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting carotid arterial disease or death from carotid arterial disease with the circumstances of a person’s relevant service are:

 

(a)               the presence of hypertension before the clinical onset of carotid arterial disease; or

 

(b)              the presence of dyslipidaemia before the clinical onset of carotid arterial disease; or

 

(c)              suffering from diabetes mellitus before the clinical onset of carotid arterial disease; or

 

(d)              smoking at least 15 pack years of cigarettes or the equivalent thereof in other tobacco products, before the clinical onset of carotid arterial disease and where smoking has ceased the clinical onset has occurred within 30 years of cessation; or

 

(e)              for dissection of the common, internal or external carotid artery only, suffering trauma to the neck or the base of the skull within the 12 months immediately before the clinical onset of carotid arterial disease; or

 

(f)               for aneurysm of the common, internal or external carotid artery only, suffering trauma to the affected segment of the artery before the clinical onset of carotid arterial disease; or

 

(g)              undergoing a course of therapeutic radiation to the neck or the head before the clinical onset of carotid arterial disease; or

 

(h)              suffering from hyperhomocystinaemia at the time of the clinical onset of carotid arterial disease; or

 

(i)                suffering from infective or noninfective vasculitis of the affected segment of the artery at the time of the clinical onset of carotid arterial disease; or

 

(j)                suffering from fibromuscular dysplasia or a connective tissue disorder, involving the affected segment of the artery at the time of the clinical onset of carotid arterial disease; or

 

(k)              the presence of hypertension before the clinical worsening of carotid arterial disease; or

 

(l)                the presence of dyslipidaemia before the clinical worsening of carotid arterial disease; or

 

(m)            suffering from diabetes mellitus before the clinical worsening of carotid arterial disease; or

 

(n)              smoking at least 15 pack years of cigarettes or the equivalent thereof in other tobacco products, before the clinical worsening of carotid arterial disease and where smoking has ceased the clinical worsening has occurred within 30 years of cessation; or

 

(o)              for dissection of the common, internal or external carotid artery only, suffering trauma to the neck or the base of the skull within the 12 months immediately before the clinical worsening of carotid arterial disease; or

 

(p)              for aneurysm of the common, internal or external carotid artery only, suffering trauma to the affected segment of the artery before the clinical worsening of carotid arterial disease; or

 

(q)              undergoing a course of therapeutic radiation to the neck or the head before the clinical worsening of carotid arterial disease; or

 

(r)               suffering from hyperhomocystinaemia at the time of the clinical worsening of carotid arterial disease; or

 

(s)               suffering from infective or noninfective vasculitis of the affected segment of the artery at the time of the clinical worsening of carotid arterial disease; or

 

(t)                suffering from fibromuscular dysplasia or a connective tissue disorder, involving the affected segment of the artery at the time of the clinical worsening of carotid arterial disease; or

 

(u)              inability to obtain appropriate clinical management for carotid arterial disease.

 

Factors that apply only to material contribution or aggravation

6.         Paragraphs 5(k) to 5(u) apply only to material contribution to, or aggravation of, carotid arterial disease where the person’s carotid arterial disease was suffered or contracted before or during (but not arising out of) the person’s relevant service; paragraph 8(1)(e), 9(1)(e), 70(5)(d) or 70(5A)(d) of the Act refers.

 

Inclusion of Statements of Principles

7.         In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles.

 

Other definitions

8.                  For the purposes of this Statement of Principles:

“a course of therapeutic radiation” means one or more fractions (treatment portions) of ionising radiation administered with the aim of achieving palliation or cure with gamma rays, x-rays, alpha particles or beta particles;

 

“connective tissue disorder” means Ehlers-Danlos syndrome, Marfan’s syndrome or cystic medial necrosis;

 

“death from carotid arterial disease” in relation to a person includes death from a terminal event or condition that was contributed to by the person’s carotid arterial disease;

 

“dyslipidaemia” generally means evidence of a persistently abnormal lipid profile after the accurate evaluation of serum lipids following a 12 hour overnight fast, and estimated on a minimum of two occasions as a:

        total serum cholesterol level greater than or equal to 5.5 mmol/L; or

        fasting serum triglyceride level greater than or equal to 2.0 mmol/L together with high density lipoprotein cholesterol level less than 0.9 mmol/L;

 

Note: the source for this definition is: NHF Australia, Guide to Plasma Lipids for Doctors; Current Therapeutics, Vol 33 Supplement 1, 1992

 

“hyperhomocystinaemia” means a condition characterised by an excess of homocystine in the blood;

 

“ICD-10-AM code” means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th revision, Australian Modification (ICD-10-AM), Third Edition, effective date of 1 July 2002, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 1 86487 413 9;

 

“pack years of cigarettes or the equivalent thereof in other tobacco products” means a calculation of consumption where one pack year of cigarettes equals twenty tailor made cigarettes per day for a period of one calendar year, or 7 300 cigarettes.  One tailor made cigarette approximates one gram of tobacco or one gram of cigar or pipe tobacco by weight.  One pack year of tailor made cigarettes equates to 7 300 cigarettes, or 7.3kg of smoking tobacco by weight.  Tobacco products means either cigarettes, pipe tobacco or cigars smoked, alone or in any combination;

 

“relevant service” means:

(a)     operational service; or

(b)     peacekeeping service; or

(c)                                      hazardous service;

 

“terminal event” means the proximate or ultimate cause of death and includes:

(a)              pneumonia;

(b)              respiratory failure;

(c)              cardiac arrest;

(d)              circulatory failure; or

(e)              cessation of brain function;

 

“trauma to the neck or the base of the skull” means

(i)                             a penetrating injury to the affected segment of the artery, or

(ii)                           a non-penetrating injury, involving extension or hyperflexion of the neck, or

(iii)                        an injury resulting in fracture or dislocation of the cervical spine;

 

“trauma to the affected segment of the artery” means

(i)                             a penetrating injury to the affected segment of the artery, or

(ii)                           a blunt injury resulting in soft tissue injury adjacent to the affected segment of the artery.

 

Application

9.         This Instrument applies to all matters to which section 120A of the Act applied.

 


 

Notes to Statement of Principles concerning carotid arterial disease (Instrument No. 9 of 2003)

The Statement of Principles concerning carotid arterial disease (Instrument No. 9 of 2003) in force under section 196B(2) of the Veterans’ Entitlements Act 1986, as shown in this compilation is amended as indicated in the Tables below.

Table of Instruments

Title

Date of notification
in Gazette or FRLI registration

Date of
commencement

Application, saving or
transitional provisions

Statement of Principles concerning carotid arterial disease (Instrument No. 9 of 2003)

16 April 2003

(see Gazette 2003, No. GN15)

16 April 2003

 

Amendment of Statement of Principles concerning carotid arterial disease (Instrument No. 29 of 2003)

16 July 2003

(see Gazette 2003, No. GN28)

16 July 2003

 


Table of Amendments

ad. = added or inserted      am. = amended      rep. = repealed      rs. = repealed and substituted

Provision affected

How affected

Paragraph 8 – ‘trauma to the site of the aneurysm’

rs. Instrument  No.29 of 2003

 

Back to Top Back to Top